Logo

Biomax Informatics Raises EUR2.25M in VC Funding

Oct 13, 2004

This article has been updated from an  earlier version to reflect that Biomax Solutions is independent of Biomax Informatics.

 

NEW YORK, Oct. 13 (GenomeWeb News) - Biomax Informatics has raised €2.25 million ($2.75 million) in venture capital funding, the Munich-based company said yesterday.

 

Investors included BayBG Bayerische Beteiligungsgesellschaft, Ecos Venture Capital Beteiligungs AG, and S-UBG Bayern Gesellschaft  f r  Unternehmensbeteiligungen. There was no lead investor, according to Biomax CFO Hein Osenberg.

 

Biomax plans to use the funding to develop new products and to expand its business in the US. Osenberg told GenomeWeb News that the company wants to expand its marketing and sales activies in the US, working together with its independent US partner, Biomax Solutions, which is based in Falmouth, Mass.

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.